DrugPatentWatch Database Preview
Drugs in Development Information for Vilaprisan
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Vilaprisan?
Vilaprisan is an investigational drug.
There have been 15 clinical trials for Vilaprisan.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 24th 2018.
The most common disease conditions in clinical trials are Leiomyoma, Myofibroma, and Endometriosis. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are three US patents protecting this investigational drug and eighty-one international patents.
Summary for Vilaprisan
| US Patents | 3 |
| International Patents | 81 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-01-24) |
| Vendors | 2 |
Recent Clinical Trials for Vilaprisan
| Title | Sponsor | Phase |
|---|---|---|
| Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | Bayer | Phase 3 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis | Bayer | Phase 2 |
| A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding | Bayer | Phase 3 |
Clinical Trial Summary for Vilaprisan
Top disease conditions for Vilaprisan
Top clinical trial sponsors for Vilaprisan
US Patents for Vilaprisan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | Start Trial |
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Bayer Pharma Aktiengesellschaft (Berlin, DE) | Start Trial |
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vilaprisan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vilaprisan | Argentina | 077491 | 2029-07-20 | Start Trial |
| Vilaprisan | Australia | 2010275849 | 2029-07-20 | Start Trial |
| Vilaprisan | Brazil | 112012001344 | 2029-07-20 | Start Trial |
| Vilaprisan | Canada | 2768407 | 2029-07-20 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
